David Harry Miller

David Harry Miller's AcademicInfluence.com Rankings

David Harry Miller

Philosophy

#10455

World Rank

#14329

Historical Rank

Logic

#7342

World Rank

#9073

Historical Rank

philosophy Degrees

Download Badge

Philosophy

David Harry Miller's Degrees

Doctorate Medicine Harvard University

Why Is David Harry Miller Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David Harry Miller's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Rising Incidence of Small Renal Masses: A Need to Reassess Treatment Effect (2006) (700)
Rising incidence of small renal masses: a need to reassess treatment effect. (2007) (437)
Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. (2005) (388)
Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. (2012) (380)
National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? (2006) (341)
Partial nephrectomy for small renal masses: an emerging quality of care concern? (2006) (324)
Prostate Cancer,,Version 2.2014 Clinical Practice Guidelines in Oncology (2014) (277)
Large variations in Medicare payments for surgery highlight savings potential from bundled payment programs. (2011) (274)
Identifying risk factors for potentially avoidable complications following radical cystectomy. (2005) (256)
Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. (2006) (237)
Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer. (2015) (214)
Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology. (2012) (194)
Prostate carcinoma presentation, diagnosis, and staging (2003) (183)
Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. (2004) (156)
Volume-based referral for cancer surgery: informing the debate. (2006) (136)
The impact of co-morbid disease on cancer control and survival following radical cystectomy. (2003) (135)
Processed total motile sperm count correlates with pregnancy outcome after intrauterine insemination. (2002) (131)
The demographic burden of urologic diseases in America. (2009) (104)
Functional Recovery, Oncologic Outcomes and Postoperative Complications after Robot‐Assisted Radical Prostatectomy: An Evidence‐Based Analysis Comparing the Retzius Sparing and Standard Approaches (2017) (102)
Cancer survivorship: challenges and changing paradigms. (2008) (97)
Measuring to Improve: Peer and Crowd-sourced Assessments of Technical Skill with Robot-assisted Radical Prostatectomy. (2016) (97)
Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference. (2006) (91)
Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence. (2016) (89)
The regionalization of radical cystectomy to specific medical centers. (2005) (88)
Laparoscopy for renal cell carcinoma: diffusion versus regionalization? (2006) (80)
The effects of adjusting for case mix on mortality and length of stay following radical cystectomy. (2006) (80)
Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men. (2003) (79)
A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy. (2015) (78)
Variations in quality of care for men with early-stage prostate cancer. (2008) (77)
Hospice use and high-intensity care in men dying of prostate cancer. (2011) (74)
A matched comparison of perioperative outcomes of a single laparoscopic surgeon versus a multisurgeon robot-assisted cohort for partial nephrectomy. (2012) (70)
Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer. (2014) (70)
Medicare's New Bundled Payment For Joint Replacement May Penalize Hospitals That Treat Medically Complex Patients. (2016) (69)
Contemporary clinical epidemiology of renal cell carcinoma: insight from a population based case-control study. (2010) (68)
Trends in the diffusion of laparoscopic nephrectomy. (2006) (66)
Getting under the hood of the volume-outcome relationship for radical cystectomy. (2006) (66)
Prostate Cancer Registries: Current Status and Future Directions. (2016) (64)
Effect of insurance expansion on utilization of inpatient surgery. (2014) (62)
Prostate cancer severity among low income, uninsured men. (2008) (61)
External validation of a claims-based algorithm for classifying kidney-cancer surgeries (2009) (58)
Regional collaboration to improve radiographic staging practices among men with early stage prostate cancer. (2011) (57)
The management of a clinical t1b renal tumor in the presence of a normal contralateral kidney. (2013) (56)
Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy. (2013) (56)
Independent surgical validation of the new prostate cancer grade‐grouping system (2016) (54)
Complications and failure to rescue after laparoscopic versus open radical nephrectomy. (2011) (54)
Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices (2017) (52)
Anticipating the effects of accountable care organizations for inpatient surgery. (2013) (52)
Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative. (2014) (51)
What is the fate of the refluxing contralateral kidney in children with multicystic dysplastic kidney? (2004) (50)
Establishment of a urological surgery quality collaborative. (2010) (50)
Percutaneous cystolithotomy using a laparoscopic entrapment sac. (2003) (50)
Racial disparities in resource utilization for cystectomy. (2006) (49)
Utilization and outcomes of inpatient surgical care at critical access hospitals in the United States. (2013) (47)
Early impact of Medicare accountable care organizations on cancer surgery outcomes (2016) (46)
Use of advanced treatment technologies among men at low risk of dying from prostate cancer. (2013) (46)
Drivers of Payment Variation in 90-Day Coronary Artery Bypass Grafting Episodes (2017) (46)
Successful angioembolization of renal artery pseudoaneurysms after blunt abdominal trauma. (2002) (46)
Tumor enucleation vs sharp excision in minimally invasive partial nephrectomy: technical benefit without impact on functional or oncologic outcomes. (2014) (45)
Discharge practice patterns following cystectomy for bladder cancer: evidence for the shifting of the burden of care. (2006) (45)
Understanding the use of immediate intravesical chemotherapy for patients with bladder cancer. (2012) (45)
Practice- vs Physician-Level Variation in Use of Active Surveillance for Men With Low-Risk Prostate Cancer: Implications for Collaborative Quality Improvement (2017) (45)
Appropriateness Criteria for Active Surveillance of Prostate Cancer (2017) (44)
Impact of surgical volume on mortality and length of stay after nephrectomy. (2004) (43)
The effects of stage divergence on survival after radical cystectomy for urothelial cancer. (2005) (42)
Toward better use of bone scans among men with early-stage prostate cancer. (2014) (42)
Practice based collaboration to improve the use of immediate intravesical therapy after resection of nonmuscle invasive bladder cancer. (2013) (42)
Molecular and Immunohistochemical Characterization Reveals Novel BRAF Mutations in Metanephric Adenoma (2015) (41)
Does robotic technology mitigate the challenges of large prostate size? (2010) (41)
Comparing performance of Morbidity and Mortality Conference and National Surgical Quality Improvement Program for detection of complications after urologic surgery. (2006) (40)
Mortality after urologic cancer surgery: impact of non-index case volume. (2008) (39)
Primary and salvage cryotherapy for prostate cancer. (2010) (39)
Development and Validation of an Objective Scoring Tool for Robot‐Assisted Radical Prostatectomy: Prostatectomy Assessment and Competency Evaluation (2017) (38)
Surgical management of low-stage renal cell carcinoma: Technology does not supersede biology. (2006) (37)
Understanding the role of percutaneous biopsy in the management of patients with a small renal mass. (2012) (37)
Costs of Cancer Care Across the Disease Continuum (2018) (35)
Adding A Spending Metric To Medicare's Value-Based Purchasing Program Rewarded Low-Quality Hospitals. (2016) (35)
Population‐level comparative effectiveness of laparoscopic versus open radical nephrectomy for patients with kidney cancer (2011) (34)
Quality of life and satisfaction among prostate cancer patients followed in a dedicated survivorship clinic (2015) (34)
Use of quality indicators to evaluate the care of patients with localized prostate carcinoma (2003) (34)
Identifying Drivers of Episode Cost Variation With Radical Prostatectomy. (2016) (34)
Population level assessment of hospital based outcomes following laparoscopic versus open partial nephrectomy during the adoption of minimally invasive surgery. (2014) (34)
The economic burden of prostate cancer survivorship care. (2010) (33)
Quality indicators in the management of bladder cancer. (2013) (32)
Understanding criteria for surveillance of patients with a small renal mass. (2012) (31)
Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival. (2018) (31)
Robot-assisted retroperitoneal partial nephrectomy: technique and perioperative results. (2011) (30)
Validation of a claims-based algorithm to characterize episodes of care. (2017) (30)
Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision? (2016) (30)
A Statewide Intervention Improves Appropriate Imaging in Localized Prostate Cancer (2017) (30)
Clinical predictors and recommendations for staging computed tomography scan among men with prostate cancer. (2014) (29)
Quality of Care in Urology and the Michigan Urological Surgery Improvement Collaborative (2014) (29)
askMUSIC: Leveraging a Clinical Registry to Develop a New Machine Learning Model to Inform Patients of Prostate Cancer Treatments Chosen by Similar Men. (2019) (29)
Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors (2015) (29)
Treatment Choice and Quality of Care for Men With Localized Prostate Cancer (2007) (29)
Hospital Characteristics and Use of Innovative Surgical Therapies Among Patients With Kidney Cancer (2008) (28)
Surgeon characteristics and long-term trends in the adoption of laparoscopic radical nephrectomy. (2011) (28)
Quality of care indicators for prostate cancer: progress toward consensus. (2009) (28)
Measuring the quality of care for localized prostate cancer. (2005) (28)
Comparative effectiveness of external-beam radiation approaches for prostate cancer. (2014) (27)
Implications of the Definition of an Episode of Care Used in the Comprehensive Care for Joint Replacement Model (2017) (27)
A Roadmap for Improving the Management of Favorable Risk Prostate Cancer. (2017) (26)
Video review for measuring and improving skill in urological surgery (2019) (26)
Racial Disparities in Access to Care for Men in a Public Assistance Program for Prostate Cancer (2008) (25)
MUSIC: patterns of care in the radiographic staging of men with newly diagnosed low risk prostate cancer. (2015) (25)
Association of Postdischarge Spending and Performance on New Episode-Based Spending Measure. (2016) (25)
Improvement in clinical TNM staging documentation within a prostate cancer quality improvement collaborative. (2014) (25)
Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data (2017) (25)
Establishment of a Web-based System for Collection of Patient-reported Outcomes After Radical Prostatectomy in a Statewide Quality Improvement Collaborative. (2017) (24)
Examining the Value of Video Visits to Patients in an Outpatient Urology Clinic. (2017) (24)
Multi-institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial Nephrectomy. (2018) (24)
Evaluating the Accreditation Council on Graduate Medical Education core clinical competencies: techniques and feasibility in a urology training program. (2003) (24)
Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance (2018) (23)
Matched comparison of robotic vs laparoscopic nephroureterectomy: an initial experience. (2014) (23)
National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms. (2018) (23)
Association Between Hospital Participation in Medicare Shared Savings Program Accountable Care Organizations and Readmission Following Major Surgery (2019) (22)
Treating older men with prostate cancer: survival (or selection) of the fittest? (2006) (22)
Specialty-Specific Trends in the Prevalence and Distribution of Outpatient Surgery (2014) (21)
Missing the mark on prostate-specific antigen screening. (2011) (20)
Use of nephrectomy at select medical centers--a case of follow the crowd? (2006) (20)
Comparison of Pathological Outcomes for Men with Low Risk Prostate Cancer from Diverse Practice Settings: Similar Results from Immediate Prostatectomy or Initial Surveillance with Delayed Prostatectomy. (2016) (20)
Surgery and Medicare Shared Savings Program Accountable Care Organizations. (2016) (20)
Notable Outcomes and Trackable Events after Surgery: Evaluating an Uncomplicated Recovery after Radical Prostatectomy. (2016) (19)
Long-term renal functional outcomes of minimally invasive partial nephrectomy for renal cell carcinoma. (2014) (19)
PROSTATE CANCER TREATMENT FOR ECONOMICALLY DISADVANTAGED MEN: A COMPARISON OF COUNTY HOSPITALS AND PRIVATE PROVIDERS (2009) (19)
Association Between Patient Satisfaction and Short-Term Outcomes After Major Cancer Surgery (2017) (19)
Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care (2018) (19)
Risk of Becoming Lost to Follow-up During Active Surveillance for Prostate Cancer. (2018) (18)
Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries. (2011) (18)
Surgical approach and the use of lymphadenectomy and adrenalectomy among patients undergoing radical nephrectomy for renal cell carcinoma. (2012) (18)
Urologist Participation in Medicare Shared Savings Program Accountable Care Organizations (ACOs). (2016) (18)
Utilization of Salvage Radiation Therapy for Biochemical Recurrence After Radical Prostatectomy. (2019) (18)
Clinical Utility of Gene Expression Classifiers in Men With Newly Diagnosed Prostate Cancer. (2018) (18)
Implications of evolving delivery system reforms for prostate cancer care. (2016) (18)
Sharp Decline In Prostate Cancer Treatment Among Men In The General Population, But Not Among Diagnosed Men. (2017) (18)
Differential adoption of laparoscopy by treatment indication. (2007) (17)
Comparison of Percutaneous Renal Mass Biopsy and R.E.N.A.L. Nephrometry Score Nomograms for Determining Benign Vs Malignant Disease and Low-risk Vs High-risk Renal Tumors. (2016) (17)
Initial patterns of care with oral targeted therapies for patients with renal cell carcinoma. (2011) (17)
Cost trends for oncological renal surgery: support for a laparoscopic standard of care. (2005) (16)
The utility of lockout valve reservoirs in preventing autoinflation in penile prostheses (2004) (16)
Functional Outcomes Following Nerve Sparing Prostatectomy Augmented with Seminal Vesicle Sparing Compared to Standard Nerve Sparing Prostatectomy: Results from a Randomized Controlled Trial (2017) (16)
Utilization and Outcomes of Inpatient Urological Care at Safety Net Hospitals. (2015) (16)
The delivery of prostate cancer care in the United States: implications for delivery system reform. (2010) (16)
Trends in urology graduate medical education: a brief update from the Urology Residency Review Committee. (2004) (16)
Postoperative complications and long-term survival among patients treated surgically for renal cell carcinoma. (2012) (16)
Understanding the relationship between the Centers for Medicare and Medicaid Services' Hospital Compare star rating, surgical case volume, and short‐term outcomes after major cancer surgery (2017) (16)
Transfer rates and use of post-acute care after surgery at critical access vs non-critical access hospitals. (2014) (16)
Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancer. (2014) (16)
Variation in prostate cancer detection rates in a statewide quality improvement collaborative. (2014) (15)
Episode-based Payment Variation for Urologic Cancer Surgery. (2018) (15)
Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomy. (2016) (15)
Adherence to performance measures and outcomes among men treated for prostate cancer. (2014) (15)
Prostate cancer family history and eligibility for active surveillance: a systematic review of the literature (2017) (15)
Effect of delayed resection after initial surveillance and tumor growth rate on final surgical pathology in patients with small renal masses (SRMs). (2016) (15)
Comparing Publicly Reported Surgical Outcomes With Quality Measures From a Statewide Improvement Collaborative. (2016) (15)
Health Care Integration and Quality among Men with Prostate Cancer (2017) (14)
Understanding treatment disconnect and mortality trends in renal cell carcinoma using tumor registry data. (2014) (14)
Collaborative quality improvement (2017) (14)
Bundling Payments for Episodes of Surgical Care. (2015) (14)
Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer. (2015) (14)
Understanding differences between high and low volume hospitals for radical prostatectomy. (2008) (13)
Understanding prostate cancer spending growth among Medicare beneficiaries. (2011) (13)
Calculating life expectancy to inform prostate cancer screening and treatment decisions (2017) (13)
Integration and Diagnostic Accuracy of 3T Nonendorectal coil Prostate Magnetic Resonance Imaging in the Context of Active Surveillance. (2018) (13)
Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal Tumors. (2016) (13)
Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy series (2014) (13)
Primary care focus and utilization in the Medicare shared savings program accountable care organizations (2017) (13)
Understanding Inpatient Cost Variation in Kidney Transplantation: Implications for Payment Reforms. (2016) (12)
Long-term oncologic outcomes of minimally invasive partial nephrectomy for renal-cell carcinoma. (2014) (12)
Insurance Expansion and the Utilization of Inpatient Surgery (2015) (12)
Local anesthesia in transrectal prostate biopsy. (2006) (12)
192 Wisdom of the crowds: Use of crowdsourcing to assess surgical skill of robot-assisted radical prostatectomy in a statewide surgical collaborative (2015) (12)
Technology diffusion and diagnostic testing for prostate cancer. (2013) (12)
Longitudinal Quality of Life in Low-Income Men in a State-Funded Prostate Cancer Treatment Program (2008) (12)
Inpatient urological surgery at critical access hospitals in the United States. (2013) (11)
Surgery: Can checklists improve surgical outcomes? (2009) (11)
Alternative payment models and urology (2017) (11)
Association Between Early Confirmatory Testing and the Adoption of Active Surveillance for Men With Favorable-risk Prostate Cancer. (2018) (11)
A Comparison of Extraperitoneal and Intraperitoneal Approaches for Robotic Prostatectomy (2012) (11)
Variation in prostate cancer care. (2015) (10)
Adverse Childhood Experiences (ACEs) and Community Physicians: What We've Learned. (2020) (10)
Evaluation of Patient- and Surgeon-Specific Variations in Patient-Reported Urinary Outcomes 3 Months After Radical Prostatectomy From a Statewide Improvement Collaborative. (2021) (10)
Understanding the Use of Prostate Biopsy Among Men with Limited Life Expectancy in a Statewide Quality Improvement Collaborative. (2016) (10)
Accountable Care Organizations and Prostate Cancer Care (2017) (10)
Patient and Provider Variables Associated with Variation in the Systemic Treatment of Advanced Prostate Cancer. (2018) (10)
Optimizing active surveillance strategies to balance the competing goals of early detection of grade progression and minimizing harm from biopsies (2018) (10)
Hypercalcemia in Upper Urinary Tract Urothelial Carcinoma: A Case Report and Literature Review (2013) (9)
Using video review to understand the technical variation of robot-assisted radical prostatectomy in a statewide surgical collaborative (2019) (9)
Medicare Accountable Care Organizations and Use of Potentially Low-Value Procedures (2018) (8)
Understanding the Performance of Active Surveillance Selection Criteria in Diverse Urology Practices. (2015) (8)
Anatomical patterns of recurrence following biochemical relapse after post‐prostatectomy salvage radiation therapy: a multi‐institutional study (2017) (8)
Assessment of the quality of medical care among patients with early stage prostate cancer undergoing expectant management in the United States. (2012) (8)
Use of nephron-sparing surgery among renal cell carcinoma patients with diabetes and hypertension. (2014) (8)
Validity of the Patient-Reported Outcome Measurement Information System (PROMIS) Sexual Interest and Satisfaction Measures in Men Following Radical Prostatectomy. (2019) (8)
Trends in the use of gross and frozen section pathological consultations during partial or radical nephrectomy for renal cell carcinoma. (2008) (8)
Utilization and Outcomes of Inpatient Surgery at Safety-Net Hospitals (2015) (8)
Phase II clinical trial of intravesical bacillus Calmette-Guerin (BCG) followed by sunitinib for the treatment of high-risk nonmuscle-invasive bladder cancer (NMIBC). (2015) (8)
MULTI‐INSTITUTIONAL SURVIVAL ANALYSIS OF INCIDENTAL PATHOLOGIC T3A UPSTAGING IN CLINICAL T1 RENAL CELL CARCINOMA FOLLOWING PARTIAL NEPHRECTOMY: MP72‐06 (2017) (8)
TECHNICAL SKILL ASSESSMENT OF SURGEONS PERFORMING ROBOT‐ASSISTED RADICAL PROSTATECTOMY: RELATIONSHIP BETWEEN CROWDSOURCED REVIEW AND PATIENT OUTCOMES: PNFBA‐02 (2017) (8)
Assessing the Performance and Validity of Diagnostic Tests and Screening Programs (2006) (7)
Anticipating the effect of the Patient Protection and Affordable Care Act for patients with urologic cancer. (2014) (7)
System-Level Health-Care Integration and the Costs of Cancer Care Across the Disease Continuum. (2018) (7)
1185: Long-Term Outcomes Among Localized Prostate Cancer Survivors: HRQOL Changes 4 to 8 Years Following Brachytherapy, External Radiation and Radical Prostatectomy (2004) (7)
Quality of care and performance-based reimbursement: the contemporary landscape and implications for urologists. (2006) (7)
Evaluation of a needle disinfectant technique to reduce infection‐related hospitalisation after transrectal prostate biopsy (2018) (7)
Long-distance longitudinal prostate MRI quality assurance: from startup to 12 months (2018) (7)
Variable penetrance of a consensus classification scheme for renal cell carcinoma. (2007) (7)
Anticipating the Impact of Insurance Expansion on Inpatient Urological Surgery (2014) (7)
Repeat Prostate Biopsy Practice Patterns in a Statewide Quality Improvement Collaborative (2017) (7)
Evaluation of Prostate Cancer Risk Calculators for Shared Decision Making Across Diverse Urology Practices in Michigan. (2017) (7)
Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations (2018) (7)
Use of Routine Home Health Care and Deviations From an Uncomplicated Recovery Pathway After Radical Prostatectomy. (2017) (6)
137: Regionalization of Radical Cystectomy (2004) (6)
Initial Observation of a Large Proportion of Patients Presenting with Clinical Stage T1 Renal Masses: Results from the MUSIC-KIDNEY Statewide Collaborative (2020) (6)
Temporary perineal urethrostomy for external sphincter dilation in a male patient with high risk myelomeningocele. (2003) (6)
Impact of Decipher Biopsy Testing on Clinical Outcomes in Localized Prostate Cancer in a Prospective Statewide Collaborative (2021) (6)
An Opportunity to Improve Medicare’s Planned Readmissions Measure (2017) (6)
Prospective randomized trial of genomic classifier impact on treatment decisions in patients at high risk of recurrence following radical prostatectomy (G-MINOR). (2018) (6)
Patient-Reported Sexual Aid Utilization and Efficacy After Radiation Therapy for Localized Prostate Cancer. (2018) (6)
Early National Dissemination of Abiraterone and Enzalutamide for Advanced Prostate Cancer in Medicare Part D. (2017) (5)
Hospital readmission after surgery: no place like home (2015) (5)
Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy series. (2014) (5)
Logic Regression for Provider Effects on Kidney Cancer Treatment Delivery (2014) (5)
Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer. (2018) (5)
Effects of laparoscopy on surgical discharge practice patterns. (2008) (5)
Payer leverage and hospital compliance with a benchmark: a population-based observational study (2007) (5)
A Management Algorithm for Mitomycin C Induced Cystitis (2017) (5)
VIDEO ANALYSIS OF SKILL AND TECHNIQUE (VAST): MACHINE LEARNING TO ASSESS SURGEONS PERFORMING ROBOTIC PROSTATECTOMY: PD46‐04 (2017) (5)
Identifying Better Practices for Early-stage Bladder Cancer (2011) (5)
Treating Older Men With Prostate Cancer (2006) (4)
MP44-11 PATIENT SELECTION AND OUTCOMES BETWEEN LOW AND HIGH VOLUME SURGEONS IN PERFORMANCE OF RADICAL PROSTATECTOMY IN THE MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE (MUSIC) (2019) (4)
21: Refining the Focus of the Volume-Outcome Relationship for Urologic Malignancies (2006) (4)
Simplifying Treatment and Reducing Recurrence for Patients With Early-Stage Bladder Cancer. (2018) (4)
Reply from Authors re: Julia Verne, Luke Hounsome, Roger Kockelbergh, Jem Rashbass. Improving Outcomes from Prostate Cancer: Unlocking the Treasure Trove of Information in Cancer Registries. Eur Urol 2016;69:1013-4. (2016) (4)
The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive Program. (2018) (4)
Exploring the Healthcare Value of Percutaneous Coronary Intervention: Appropriateness, Outcomes, and Costs in Michigan Hospitals (2018) (4)
Moving beyond the headlines: improving the technical quality of radical prostatectomy. (2014) (4)
Overtreatment and underutilization of watchful waiting in men with limited life expectancy: an analysis of the Michigan Urological Surgery Improvement Collaborative Registry. (2019) (4)
Limiting Opioid Overprescription after Prostatectomy: How Payer-Provider Collaboration Can Lead to Improved Patient Safety and Reimbursement (2020) (4)
VARIATION IN NATIONAL OPIOID PRESCRIBING PATTERNS FOLLOWING OUTPATIENT NEPHROLITHIASIS PROCEDURES: MP75‐04 (2017) (4)
Understanding pre-enrollment surgical outcomes for hospitals participating in Medicare Accountable Care Organizations. (2016) (4)
Patient- and Surgeon-Level Variation in Patient-Reported Sexual Function Outcomes Following Radical Prostatectomy Over 2 Years: Results From a Statewide Surgical Improvement Collaborativep. (2021) (3)
Association of Delivery System Integration and Outcomes for Major Cancer Surgery (2018) (3)
Association Between Delivery System Structure and Intensity of End-of-Life Cancer Care. (2020) (3)
Pelvic lymph node dissection at robot-assisted radical prostatectomy: Assessing utilization and nodal metastases within a statewide quality improvement consortium. (2019) (3)
Regular vs. selective use of closed suction drains following robot-assisted radical prostatectomy: results from a regional quality improvement collaborative (2019) (3)
Intraoperative Management of an Incidentally Identified Ectopic Ureter Inserting Into the Prostate of a Patient Undergoing Radical Prostatectomy for Prostate Cancer (2015) (3)
Prostate cancer clinical trial completion: The role of geography. (2021) (3)
Improving Colorectal Cancer Screening in a Rural Setting: A Randomized Study. (2020) (3)
SURGICAL SKILL QUALITY IMPROVEMENT: UTILIZING A PEER VIDEO REVIEW WORKSHOP FOR SURGEONS PERFORMING ROBOTIC PROSTATECTOMY: MP51‐13 (2017) (2)
Intensity of end‐of‐life care for dual‐eligible beneficiaries with cancer and the impact of delivery system affiliation (2021) (2)
SURGICAL SKILL AND PATIENT OUTCOMES AFTER ROBOT‐ASSISTED RADICAL PROSTATECTOMY: PD58‐06 (2017) (2)
The volume outcome relationship in urology: moving the field forward. (2012) (2)
PD18-02 INCREASED URINARY VASCULAR ENDOTHELIAL GROWTH FACTOR D (VEGF-D) LEVELS ARE ASSOCIATED WITH RESPONSE TO COMBINED INTRAVESICAL BACILLUS CALMETTE−GUERIN (BCG) AND ORAL SUNITINIB REGIMEN FOR TREATMENT OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) (2019) (2)
IS CROWDSOURCING SURGICAL SKILL ASSESSMENT RELIABLE? AN ANALYSIS OF ROBOTIC PROSTATECTOMIES: PD46‐03 (2017) (2)
1530 UNDERSTANDING REAL-WORLD CRITERIA FOR THE SURVEILLANCE OF PATIENTS WITH A SMALL RENAL MASS (2011) (2)
OR Practice-Data Analytics for Optimal Detection of Metastatic Prostate Cancer (2021) (2)
What is the impact of a clinically related readmission measure on the assessment of hospital performance? (2017) (2)
MP15-04 VARIATION IN ACTIVE SURVEILLANCE FOLLOW-UP OVER TWO YEARS IN DIVERSE UROLOGY PRACTICES (2016) (2)
827: Salvage Therapy Adversely Effects Long-Term Hrqol among Localized Prostate Cancer Treatment Survivors (2005) (2)
Health-Related Quality of Life Issues (2004) (2)
Prospective randomized trial of gene expression classifier utility following radical prostatectomy (G-MINOR). (2021) (2)
Variation in Physician-Specific Episode Payments for Major Cancer Surgery and Implications for the Merit-Based Incentive Program. (2019) (1)
MP6-13 INSURANCE EXPANSION AND THE UTILIZATION OF INPATIENT UROLOGICAL SURGERY (2014) (1)
65 COMPARATIVE EFFECTIVENESS OF PARTIAL VERSUS RADICAL NEPHRECTOMY IN THE TREATMENT OF PATIENTS WITH EARLY-STAGE KIDNEY CANCER (2012) (1)
MP18-10 MI TREXIT: PILOT EVALUATION OF A STATE-WIDE INITIATIVE FOR IN-OFFICE TRANSPERINEAL VERSUS TRANSRECTAL PROSTATE BIOPSY UNDER LOCAL ANESTHESIA (2019) (1)
Development and Validation of Dynamic Multivariate Prediction Models of Sexual Function Recovery in Patients with Prostate Cancer Undergoing Radical Prostatectomy: Results from the MUSIC Statewide Collaborative (2022) (1)
MP15-03 APPROPRIATENESS CRITERIA FOR ACTIVE SURVEILLANCE FOR PROSTATE CANCER FROM THE MICHIGAN UROLOGIC SURGERY IMPROVEMENT COLLABORATIVE (2016) (1)
PD42-07 IMPLEMENTATION OF METHODOLOGY TO CAPTURE DATA FROM PROSTATE MRI WITHIN A REGIONAL QUALITY-IMPROVEMENT COLLABORATIVE (2016) (1)
MP76-04 ACCOUNTABLE CARE ORGANIZATIONS AND THE COST AND QUALITY OF UROLOGICAL CANCER CARE AT THE END OF LIFE (2018) (1)
Predictors of Rapid Treatment Failure After Postoperative Radiation Therapy: A Multicenter Study (2016) (1)
1033: The Quality of Surgical Pathology Care for Men Treated with Radical Prostatectomy in the United States (2007) (1)
MEASURING TO IMPROVE: PATIENT REPORTED OUTCOMES DURING THE FIRST YEAR AFTER PROSTATECTOMY IN A STATEWIDE COLLABORATIVE: PD18‐02 (2017) (1)
Trends in Inpatient Urological Surgery Practice Patterns (2016) (1)
MP9-18 ANTICIPATING THE IMPACT OF ACCOUNTABLE CARE ORGANIZATIONS ON THE COST AND QUALITY OF UROLOGIC CANCER CARE (2015) (1)
MP25-12 ANALYSIS OF ACTIVE SURVEILLANCE FOLLOW-UP: HOW CLOSELY ARE PATIENTS MONITORED OVER TIME? (2016) (1)
PROSPECTIVE RANDOMIZED TRIAL COMPARING 6 VERSUS 12 CORES: EFFECT ON CANCER DETECTION (1999) (1)
227: Rising Incidence of Small, Organ-Confined Renal Masses: A Case for Overtreatment? (2006) (1)
MP76-05 COSTS OF UROLOGIC CANCER CARE ACROSS THE DISEASE CONTINUUM (2018) (1)
MP5-20 NOTABLE OUTCOMES AND TRACKABLE EVENTS AFTER SURGERY (NOTES): A COMPOSITE MEASURE TO ASSESS UNCOMPLICATED RECOVERY AFTER RADICAL PROSTATECTOMY (2015) (1)
1306 OUTCOMES OF PATIENTS PURSUING ACTIVE SURVEILLANCE FOR A SMALL RENAL MASS (2013) (1)
PD38-08 MULTI-INSTITUTIONAL PROSPECTIVE VALIDATION OF THE NOVEL MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE TRANSPERINEAL BIOPSY TEMPLATE (2020) (1)
Is the Fear of Postprostatectomy Radiation Therapy Justified?: An Analysis of Patient-Reported Quality of Life Following Adjuvant or Salvage Radiation (2014) (1)
Survey of Abdominal Access and Associated Morbidity for Robot-Assisted Radical Prostatectomy: Does Palmer's Point Warrant Further Awareness and Study? (2017) (1)
MP1-14 DEFINING ADVERSE PATHOLOGY FOR LOWER RISK MEN UNDERGOING RADICAL PROSTATECTOMY (2015) (1)
199: Correlates of Access to Prostate Cancer Care in a Statewide Public Assistance Program (2007) (0)
PD13-02 TRENDS IN PROSTATE CANCER TREATMENT: DATA FROM THE MICHIGAN UROLOGIC SURGICAL IMPROVEMENT COLLABORATIVE (2020) (0)
Laparoscopy and Robotic Surgery Long-Term Oncologic Outcomes of Minimally Invasive Partial Nephrectomy for Renal-Cell Carcinoma (2017) (0)
MP20-14 VARIATION IN THE TECHNICAL SKILL OF SURGEONS PERFORMING ROBOT-ASSISTED RADICAL PROSTATECTOMY (2016) (0)
PD38-11 USING VIDEO ANALYSIS TO UNDERSTAND THE TECHNICAL VARIATION OF ROBOT-ASSISTED RADICAL PROSTATECTOMY (RARP) IN A STATEWIDE SURGICAL COLLABORATIVE (2018) (0)
VARIATION IN USE OF CONFIRMATORY TESTING AMONG ACTIVE SURVEILLANCE CANDIDATES: MP43‐02 (2017) (0)
PD54-11 IMPLEMENTATION OF A STATE-WIDE QUALITY ASSURANCE INITIATIVE FOR PROSTATE MRI AND FUSION BIOPSY (2020) (0)
905: The Prevalence and Outcome of Therapy for Erectile Dysfunction 4 to 8 Years Following Brachytherapy, External Radiation and Radical Prostatectomy for Localized Prostate Cancer (2004) (0)
PD44-11 UNDERSTANDING THE PERFORMANCE OF ACTIVE SURVEILLANCE SELECTION CRITERIA IN REAL-WORLD PRACTICE (2015) (0)
MP69-19 VARIATION IN THE FREQUENCY OF PREMALIGNANT LESIONS AMONG PATIENTS UNDERGOING PROSTATE BIOPSY IN MICHIGAN (2014) (0)
231: Laparoscopic Nephrectomy: Prolonged Diffusion of a Standard of Care (2006) (0)
COMPARING PRACTICE‐ VERSUS PROVIDER‐LEVEL VARIATION IN USE OF ACTIVE SURVEILLANCE FOR MEN WITH LOW‐RISK PROSTATE CANCER: MP43‐05 (2017) (0)
PD58-02 OVER USE OF OPIOIDS AFTER PROSTATECTOMY: STATEWIDE EXPERIENCE FROM THE MICHIGAN UROLOGIC SURGERY IMPROVEMENT COLLABORATIVE (MUSIC) (2019) (0)
Finding the Nearest TRexit: Novel Transperineal Prostate Biopsy Approaches for All Practices (2020) (0)
THE QUALITY OF ACTIVE SURVEILLANCE FOR MEN WITH LOW-RISK PROSTATE CANCER (2009) (0)
MP17-02 THE IMPACT OF CONFIRMATORY TESTING ON THE ADOPTION OF ACTIVE SURVEILLANCE FOR MEN WITH FAVORABLE-RISK PROSTATE CANCER (2018) (0)
UNDERSTANDING PRE‐ENROLLMENT FIRST YEAR COSTS OF UROLOGICAL CANCER CARE FOR HOSPITALS THAT WENT ON TO PARTICIPATE IN MEDICARE ACCOUNTABLE CARE ORGANIZATIONS: PD32‐02 (2017) (0)
CAN FREQUENCY OF PROSTATE BIOPSY ON ACTIVE SURVEILLANCE BE REDUCED WITHOUT SIGNIFICANTLY INCREASING RISK?: MP43‐01 (2017) (0)
PD03-03 COMPARISON OF PATHOLOGIC OUTCOMES AT PROSTATECTOMY FOR MEN WITH LOW-RISK PROSTATE CANCER CHOOSING INITIAL ACTIVE SURVEILLANCE VERSUS PROSTATECTOMY (2016) (0)
Treating Advanced Prostate Cancer-the Human Factor. (2018) (0)
Localized kidney cancer: Changing patterns of care (2008) (0)
MP12-11 RATES AND RISK FACTORS OF LOST TO FOLLOW UP IN PROSTATE CANCER PATIENTS MANAGED WITH ACTIVE SURVEILLANCE (2018) (0)
VARIATION IN 90‐DAY EPISODE PAYMENTS FOR UROLOGICAL CANCER SURGERY: IMPLICATIONS FOR BUNDLED PAYMENT PROGRAMS: PD14‐01 (2017) (0)
MP32-02 BASELINE UTILIZATION AND OUTCOMES OF INPATIENT SURGICAL CARE FOR HOSPITALS PARTICIPATING IN ACCOUNTABLE CARE ORGANIZATIONS (2015) (0)
PD25-11 EARLY IMPACT OF MEDICARE ACCOUNTABLE CARE ORGANIZATIONS ON UROLOGICAL CANCER OUTCOMES (2016) (0)
PD30-03 DEVELOPMENT AND VALIDATION OF PROSTATECTOMY ASSESSMENT AND COMPETENCY EVALUATION SCORING FOR ROBOT-ASSISTED RADICAL PROSTATECTOMY (2016) (0)
MP66-15 MEASURING THE IMPACT OF A PHYSICIAN-LED COLLABORATIVE ON THE QUALITY OF PROSTATE CANCER CARE: 7 YEARS OF MAKING MUSIC (2020) (0)
USE OF PELVIC FLOOR REHABILITATION IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE: PATIENT AND COST CHARACTERISTICS: MP69‐03 (2017) (0)
MP02-02 THE STABILITY OF PHYSICIAN-SPENDING FOR UROLOGICAL CANCER SURGERY (2018) (0)
PD25-10 A STATEWIDE INTERVENTION TO REDUCE THE USE OF LOW VALUE IMAGING AMONG MEN WITH NEWLY-DIAGNOSED PROSTATE CANCER. (2016) (0)
PD30-12 HOSPITAL COST VARIATION FOR KIDNEY TRANSPLANTATION (2014) (0)
364 Assessment of surgical competency for robot-assisted radical prostatectomy: Development and validation of Prostatectomy Assessment and Competency Evaluation (PACE) (2016) (0)
MP31-05 TRENDS IN INPATIENT UROLOGICAL SURGERY PRACTICE PATTERNS (2016) (0)
Poster ViewingIntermediate Endpoints After Postprostatectomy Radiation Therapy: 5-Year Distant Metastases to Predict Overall Survival (2017) (0)
721: Predicting Long-Term Survival Following Surgery for Renal Cell Carcinoma: How do We Counsel Our Patients? (2006) (0)
MP58-18 TRANSRECTAL MRI/US FUSION BIOPSY DOUBLES THE RISK OF INFECTIOUS HOSPITALIZATION - ANALYSIS OF A STATEWIDE COLLABORATIVE (2020) (0)
MP76-01 VARIATION IN PHYSICIAN-SPECIFIC EPISODE PAYMENTS FOR MAJOR UROLOGIC CANCER SURGERY: IMPLICATIONS FOR MIPS (2018) (0)
PD54-05 ARE ALL FUSION BIOPSIES CREATED EQUAL? SUBSTANTIAL PRACTICE-LEVEL VARIATION IN A STATE-WIDE QUALITY IMPROVEMENT COLLABORATIVE (2020) (0)
CENTERS FOR MEDICARE AND MEDICAID SERVICES' (CMS) HOSPITAL COMPARE STAR RANKINGS AND SHORT‐TERM OUTCOMES AFTER MAJOR UROLOGICAL CANCER SURGERY: PD14‐02 (2017) (0)
PD43-12 PROMIS INTEREST IN SEXUAL ACTIVITY AND SATISFACTION WITH SEX LIFE MEASURES IN MEN WITH PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY (2019) (0)
Results from the seminal vesicle sparing prostatectomy trial. (2014) (0)
PD25-07 IDENTIFYING DRIVERS OF TOTAL EPISODE COST VARIATION IN RADICAL PROSTATECTOMY (2016) (0)
MP42-01 MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE: PATTERNS OF CARE IN THE RADIOGRAPHIC STAGING OF MEN WITH NEWLY DIAGNOSED PROSTATE CANCER (2014) (0)
General & Epidemiological Trends & Socioeconomics: Value of Care: Cost and Outcomes Measures IPD25-12 UROLOGIST PARTICIPATION IN MEDICARE SHARED SAVINGS PROGRAM ACCOUNTABLE CARE ORGANIZATIONS (ACOS) (2016) (0)
DETERMINANTS OF RADICAL PROSTATECTOMY IN THE PROSTATE, LUNG, COLORECTAL, OVARIAN (PLCO) CANCER SCREENING TRIAL (2008) (0)
PD51-11 INSTITUTION OF A SMALL RENAL MASS QUALITY IMPROVEMENT INITIATIVE IN A STATEWIDE COLLABORATIVE (2018) (0)
MP16-14 THE UNPREDICTABILITY OF SOCIAL CONTINENCE AFTER RADICAL PROSTATECTOMY (2018) (0)
379: Racial Disparities in Radical Cystectomy Resource Utilization (2004) (0)
MP04-10 TRENDS AND REGIONAL VARIATION IN PROSTATE CANCER TREATMENT (2016) (0)
MP44-08 QUALITY OF UROLOGICAL CANCER CARE AT THE END OF LIFE FOR DUAL ELIGIBLE BENEFICIARIES AND THE IMPACT OF DELIVERY SYSTEM INTEGRATION (2019) (0)
207: Prostate Cancer Quality of Care: The American College of Surgeons Special Study (2006) (0)
MP73-03 COMPARISON OF ACCURACY OF RISK-STRATIFICATION OF SMALL RENAL MASSES (SRMS) WITH ALGORITHM BASED ON PERCUTANEOUS RENAL MASS BIOPSY (RMB) AND MASS SIZE VERSUS NOMOGRAMS BASED ON R.E.N.A.L. NEPHROMETRY SCORE (RNS) (2016) (0)
PD38-06 UNDERSTANDING THE USE OF PROSTATE BIOPSY AMONG MEN WITH LIMITED LIFE EXPECTANCY (2015) (0)
Assessing quality of care for prostate cancer (2005) (0)
Ranking Important Factors for Using Postoperative Chemotherapy in Nonmuscle Invasive Bladder Cancer: Conjoint Analysis Results From the Michigan Urological Surgery Improvement Collaborative (MUSIC) (2021) (0)
PD52-02 IDENTIFYING ACTIVE SURVEILLANCE IN CLAIMS DATA (2018) (0)
1597: Local Therapies for Low-Risk Prostate Cancer: Exploring the Potential Burden of Overtreatment (2006) (0)
1128: The Effect of Hospital Type and Case Volume on the Delivery of Radiation Therapy for Localized Prostate Cancer: Insight From an American College of Surgeons Special Study (2006) (0)
MP23-14 PREDICTING TREATMENT-FREE SURVIVAL FOR PATIENTS WITH LOCALIZED PROSTATE CANCER ON ACTIVE SURVEILLANCE: RESULTS FROM THE MUSIC STATEWIDE COLLABORATIVE (2020) (0)
388: Determinants of Patient Satisfaction Following Contemporary Therapy for Localized Prostate Cancer: Characterizing the Quality of Cancer Care and the Clinical Relevance of Long-Term HRQOL Outcomes (2004) (0)
1501 ESTABLISHING A THRESHOLD FOR PSA DOUBLING TIME IN PREDICTING OUTCOMES FOLLOWING SALVAGE RADIATION THERAPY (2013) (0)
MP31-04 WIDE VARIATION IN SURGEON PARTICIPATION IN EARLY MEDICARE ACCOUNTABLE CARE ORGANIZATIONS (2016) (0)
MP44-09 OVERTREATMENT AND UNDERUTILIZATION OF WATCHFUL WAITING IN MEN WITH LIMITED LIFE EXPECTANCY: AN ANALYSIS OF THE MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE REGISTRY (2019) (0)
PROSTATE CANCER RISK AND INITIAL TREATMENT DECISIONS IN THE PLCO CANCER SCREENING TRIAL (2008) (0)
MP60-07 DETERMINING THE IMPACT OF GENOMIC CLASSIFIER TESTING ON PATIENT-REPORTED QUALITY OF LIFE IN MEN AT HIGH-RISK OF POST-PROSTATECTOMY RECURRENCE: RESULTS FROM THE G-MINOR TRIAL (2021) (0)
PD56-08 MOLECULAR CLASSIFIER TESTING FOR NEWLY DIAGNOSED LOCALIZED PROSTATE CANCER IN THE STATE OF MICHIGAN (2018) (0)
PD58-07 HEALTH SYSTEM CHARACTERISTICS AND THE QUALITY OF UROLOGICAL CANCER CARE AT THE END OF LIFE (2019) (0)
PD47-06 PATHOLOGICAL UPGRADING FROM GLEASON 3+3 DISEASE AFTER RADICAL PROSTATECTOMY: THE IMPLICATIONS FOR CONFIRMATORY TESTING (2018) (0)
MP83-09 EVALUATING THE INDICATIONS AND SAFETY OF PROSTATE BIOPSIES PERFORMED IN ELDERLY PATIENTS: A REVIEW OF A STATEWIDE COLLABORATIVE (2020) (0)
PD25-08 UNDERSTANDING THE RELATIONSHIP BETWEEN EPISODE COSTS AND DEVIATIONS FROM AN UNCOMPLICATED RADICAL PROSTATECTOMY RECOVERY PATHWAY (2016) (0)
MP54-12 PROSPECTIVE RANDOMIZED TRIAL OF GENE EXRESSION CLASSIFIER UTILTY IN MEN AT HIGH RISK OF RECURRENCE FOLLOWING RADICAL PROSTATECTOMY (2019) (0)
1818 COMPARATIVE EFFECTIVENESS OF EXTERNAL BEAM RADIATION APPROACHES FOR PROSTATE CANCER (2012) (0)
Gastrointestinal and Urinary Events: Key Deviation Drivers from an Uncomplicated Radical Prostatectomy Recovery Pathway (2015) (0)
MP20-15 PROSPECTIVE EVALUATION OF A NOVEL TRANSPERINEAL ELECTROMAGNETICALLY-TRACKED MR/US FUSION BIOPSY SYSTEM (2019) (0)
PD19-06 VIDEO-BASED PEER REVIEW OF ROBOT-ASSISTED RADICAL PROSTATECTOMY IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE (2015) (0)
MP16-08 ANTICIPATING THE IMPACT OF THE AFFORDABLE CARE ACT ON UROLOGIC CARE AT SAFETY-NET HOSPITALS (2015) (0)
MP42-08 INSTITUTION OF A WEB-BASED PATIENT-REPORTED OUTCOMES (PRO) SYSTEM FOR RADICAL PROSTATECTOMY IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE (2015) (0)
Collaborative Quality Initiatives (2018) (0)
Patient-Reported Outcomes for Quality of Life (QOL) by Expanded Prostate Cancer Index (EPIC) 15 Years Posttreatment (2014) (0)
PD10-05 COMPARISON OF PUBLICLY REPORTED SURGICAL OUTCOMES WITH QUALITY MEASURES FROM A STATEWIDE SURGICAL IMPROVEMENT COLLABORATIVE (2016) (0)
PD12-02 UTILIZATION AND OUTCOMES OF REPEAT PROSTATE BIOPSY IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE (2015) (0)
870: Laparoscopy for Renal Cell Carcinoma: Diffusion Versus Regionalization of a New Standard of Care? (2006) (0)
Prognostic significance of perineural invasion in localized prostate cancer. (2015) (0)
1345 UNDERSTANDING THE IMPACT OF THE DOMINANT NODULE AND SIZE OF THE PROSTATE ON BIOCHEMICAL RECURRENCE IN MEN WITH PROSTATE CANCER (2013) (0)
483 Video-based independent peer review of robot-assisted radical prostatectomy in a statewide quality improvement collaborative (2015) (0)
1901: Payer Leverage and Hospital Compliance with a Benchmark: Medicare's Transplant Experience (2007) (0)
Quality assurance in urologic oncology: a radical prostatectomy experience of 2254 cases (2005) (0)
Title Prostate Cancer Registries : Current Status and Future Directions Permalink (2016) (0)
294: Laparoscopy, Partial Nephrectomy and the Surgical Management of Kidney Cancer in the United States (2007) (0)
PD26-02 USING A PREBIOPSY CHECKLIST TO UNDERSTAND RISK FACTORS ASSOCIATED WITH INFECTION-RELATED HOSPITALIZATION FOLLOWING PROSTATE BIOPSY (2016) (0)
133: Factors Associated with Increased Resource Utilization Following Radical Cystectomy (2004) (0)
Can frequency of prostate biopsy on active surveillance be reduced without significantly increasing risk (2017) (0)
PD02-05 SURVIVAL AMONG PATIENTS WITH UROLOGIC MALIGNANCIES TREATED AT SAFETY NET CANCER CENTERS (2016) (0)
Comparison of treatment modalities for localized prostate cancer using quality-of-life measures (2008) (0)
56 PRACTICE-BASED COLLABORATION TO IMPROVE THE USE OF IMMEDIATE INTRAVESICAL CHEMOTHERAPY (IVC) FOR NON-MUSCLE-INVASIVE BLADDER CANCER (2013) (0)
413 INPATIENT UROLOGIC CARE IN CRITICAL ACCESS HOSPITALS (2012) (0)
Oncology : Prostate / Testis / Penis / Urethra A Statewide Intervention Improves Appropriate Imaging in Localized Prostate Cancer (2017) (0)
MP76-03 MARKED VARIATION IN PROSTATE CANCER CARE AMONG ACCOUNTABLE CARE ORGANIZATIONS (2018) (0)
490: Renal Health Outcomes Following Radical or Partial Nephrectomy for Renal Cell Carcinoma (2007) (0)
CORRELATION BETWEEN A GENOMICS TEST AND ADVERSE PATHOLOGY AFTER RADICAL PROSTATECTOMY AMONG ACTIVE SURVEILLANCE CANDIDATES: PD28‐03 (2017) (0)
Reply to K.P. Weinfurt et al. (2020) (0)
PD38-13 REPEAT BIOPSY RATES FOR PREMALIGNANT LESIONS IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE (2015) (0)
(219) Epiduralgrams: Characteristics of Contrast Flow Within the Epidural Space (2001) (0)
563: Trends in the Use of Intraoperative Pathological Consulation During Radical Prostatectomy? (2007) (0)
PD02-07 NEEDLE DISINFECTANT TECHNIQUE DURING PROSTATE BIOPSY IS ASSOCIATED WITH LESS INFECTION-RELATED HOSPITALIZATION: RESULTS FROM A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE (2016) (0)
MP01-09 VIDEO ANALYSIS OF SURGEONS PERFORMING ROBOT-ASSISTED RADICAL PROSTATECTOMY: IS THERE A RELATIONSHIP BETWEEN THE TIME TAKEN TO COMPLETE THE URETHROVESICAL ANASTOMOSIS WITH TECHNICAL SKILL? (2018) (0)
ROUTINE HOME HEALTH AFTER PROSTATECTOMY DOES NOT REDUCE ED VISITS OR CATHETER COMPLICATIONS: PD14‐04 (2017) (0)
MP20-03 PATIENT EXPERIENCE FOR TRANSPERINEAL BIOPSY UNDER LOCAL ANESTHESIA VERSUS TRANSRECTAL BIOPSY: RESULTS FROM THE MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE (2020) (0)
Editorial comment on: laparoscopic partial nephrectomy versus laparoscopic cryoablation for multiple ipsilateral renal tumors. (2008) (0)
MP78-10 CONTEMPORARY USE OF ADJUVANT AND SALVAGE RADIOTHERAPY FOLLOWING RADICAL PROSTATECTOMY IN THE STATE OF MICHIGAN (2015) (0)
3: Adaptability of Physician Practice Style to the Technologic Imperative (2006) (0)
MP54-11 PELVIC LYMPH NODE DISSECTION DURING ROBOTIC PROSTATECTOMY IN THE MUSIC COLLABORATIVE (2019) (0)
41 UNDERSTANDING THE COMPARATIVE EFFECTIVENESS OF LAPAROSCOPIC RADICAL NEPHRECTOMY FOR PATIENTS WITH KIDNEY CANCER (2011) (0)
SURVEY OF ABDOMINAL ACCESS AND ASSOCIATED MORBIDITY FOR ROBOT‐ASSISTED RADICAL PROSTATECTOMY (RARP)‐ DOES PALMER's POINT WARRANT FURTHER AWARENESS AND STUDY?: PD56‐12 (2017) (0)
CONTRIBUTING TO A CRISIS? DEFINING NATIONAL PATTERNS IN OPIOID PRESCRIBING AFTER OUTPATIENT VASECTOMY: PD58‐05 (2017) (0)
293: Variation in Adoption of Laparoscopy by Treatment Indication (2007) (0)
MP62-03 CONFIRMATORY TESTING OUTCOMES IN ACTIVE SURVEILLANCE: RESULTS FROM THE MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE (MUSIC) (2021) (0)
MP12-12 EVALUATING PRACTICE PATTERNS REGARDING PROSTATE BIOPSIES PERFORMED IN ELDERLY PATIENTS (2020) (0)
2215 TRANSPERINEAL MAPPING TEMPLATE PROSTATE BIOPSY AFTER PREVIOUS TRANSRECTAL ULTRASOUND PROSTATE BIOPSY DETECTS WORSE DISEASE BURDEN (2013) (0)
PRE‐OPERATIVE PREDICTORS OF INCIDENTAL PT3A UPSTAGING FOLLOWING PARTIAL NEPHRECTOMY FOR CLINICAL T1 RENAL CELL CARCINOMA: MP55‐06 (2017) (0)
WHO ARE THE EARLY ADOPTERS OF LAPAROSCOPIC RADICAL NEPHRECTOMY (2008) (0)
MP22-03 UTILIZATION OF SALVAGE RADIATION THERAPY FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2018) (0)
PD12-09 THE INCIDENCE OF ACTIVE SURVEILLANCE FOR PRIMARY MANAGEMENT OF LOW-RISK PROSTATE CANCER IN A STATE-WIDE QUALITY IMPROVEMENT COLLABORATIVE (2014) (0)
440 DECREASING HOSPITAL LENGTH OF STAY FOR PROSTATECTOMY AND CYSTECTOMY. ARE WE NEARING A THRESHOLD (2011) (0)
637: Hospital Characteristics and the Surgical Treatment of Patients with Kidney Cancer (2007) (0)
MP6-03 TOWARD BETTER RADIOGRAPHIC STAGING OF MEN WITH EARLY-STAGE PROSTATE CANCER (2014) (0)
REPEAT PROSTATE BIOPSY PRACTICE PATTERNS IN A STATEWIDE QUALITY IMPROVEMENT COLLABORATIVE: PD43‐10 (2017) (0)
206: Quality of Care for Localized Prostate Cancer: A Comparison of Radical Prostatectomy and External Beam Radiation from the National Cancer Data Base (2006) (0)
The impact of technology diffusion on treatment for prostate cancer. (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David Harry Miller?

David Harry Miller is affiliated with the following schools:

University of Michigan